Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05689281 · ClinicalTrials.gov registry record · NA

Increasing PrEP With Trans Women in the Deep South

A NA study of HIV, sponsored by CrescentCare.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05689281 is a NA study of HIV that is actively recruiting participants, run by CrescentCare. The registered enrollment target is 200 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05689281, a NA study of HIV, is actively recruiting participants, sponsored by CrescentCare.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.

Conditions Studied

Interventions

  • BEHAVIORAL Peer PrEP Navigation

Study Locations (1)

Louisiana

  • NO/AIDS Task Force d.b.a. CrescentCare - New Orleans

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-01-31
Est. Completion 2026-07-31
Phase NA

Sponsor

CrescentCare

1 total trials

What the Registry Record Tells You About NCT05689281

The ClinicalTrials.gov registry entry for NCT05689281 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The listed sponsor is CrescentCare, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Peer PrEP Navigation is the first listed.

NCT05689281 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT05689281 about?

NCT05689281 is a clinical study titled "Increasing PrEP With Trans Women in the Deep South". The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.

What is the current status of trial NCT05689281?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-01-31. Estimated completion is 2026-07-31.

What conditions does trial NCT05689281 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT05689281?

The interventions under investigation include: Peer PrEP Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05689281?

This trial is sponsored by CrescentCare, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05689281 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.